MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 3 filers reported holding MYOVANT SCIENCES LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,307,993 | +860.1% | 233,976 | +539.0% | 0.01% | +600.0% |
| Q3 2022 | $657,000 | +83.0% | 36,616 | +26.7% | 0.00% | – |
| Q2 2022 | $359,000 | +2.6% | 28,907 | +9.9% | 0.00% | – |
| Q1 2022 | $350,000 | -24.1% | 26,314 | -11.3% | 0.00% | – |
| Q4 2021 | $461,000 | -22.9% | 29,655 | +11.3% | 0.00% | – |
| Q3 2021 | $598,000 | +2.0% | 26,642 | +2.3% | 0.00% | – |
| Q2 2021 | $586,000 | -11.7% | 26,055 | -19.3% | 0.00% | – |
| Q1 2021 | $664,000 | -12.6% | 32,290 | +17.4% | 0.00% | – |
| Q4 2020 | $760,000 | -2.2% | 27,513 | -50.2% | 0.00% | – |
| Q3 2020 | $777,000 | +98.2% | 55,299 | +191.1% | 0.00% | – |
| Q2 2020 | $392,000 | +174.1% | 18,999 | -0.1% | 0.00% | – |
| Q1 2020 | $143,000 | -43.0% | 19,010 | +17.3% | 0.00% | – |
| Q4 2019 | $251,000 | +221.8% | 16,202 | +8.9% | 0.00% | – |
| Q3 2019 | $78,000 | -15.2% | 14,884 | +46.8% | 0.00% | – |
| Q2 2019 | $92,000 | -40.6% | 10,140 | -23.3% | 0.00% | – |
| Q2 2017 | $155,000 | – | 13,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 65,000 | $808,000 | 1.13% |
| Bellevue Group AG | 5,919,639 | $73,581,000 | 1.04% |
| Rhenman & Partners Asset Management AB | 310,000 | $3,853,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 279,335 | $3,472,000 | 0.22% |
| TORRAY INVESTMENT PARTNERS LLC | 81,621 | $1,015,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 302,120 | $3,755,000 | 0.14% |
| Virtus ETF Advisers LLC | 22,356 | $278,000 | 0.10% |
| Tarbox Family Office, Inc. | 27,500 | $342,000 | 0.08% |
| BOURGEON CAPITAL MANAGEMENT LLC | 15,200 | $189,000 | 0.05% |
| JANUS HENDERSON GROUP PLC | 5,449,107 | $67,735,000 | 0.05% |